Top Companies in Qatar Ringworm Market | Key Players & Insights 2026

Qatar Ringworm Market Overview

According to 6Wresearch, the Qatar ringworm market is growing steadily, primarily fueled by the country's humid climate and active lifestyle trends, which contribute to the prevalence of fungal skin infections like Tinea Corporis and Tinea Pedis. A trend toward more effective medicine delivery systems, such as long-acting antifungal creams and high-temperature-resistant powders, is also driving the industry forward.

Furthermore, the push for national pharmaceutical self-sufficiency has encouraged local manufacturers to expand their dermatological lines, ensuring a consistent supply of essential antifungal medications through both government clinics and private retail chains.

Competitive Landscape

The competitive landscape in Qatar is a sophisticated mix of multinational corporations providing research-backed innovator brands and regional players offering high-bioequivalence generics. Success in this market depends on the ability to navigate stringent MoPH registration processes while maintaining significant distribution partnerships with major retail pharmacy chains and Hamad Medical Corporation.

Below is a list of top players active in the Qatar Ringworm Market:

1. GlaxoSmithKline (GSK)

As the manufacturer of the global benchmark brand Lamisil, GSK remains a dominant force in the Qatari antifungal market, providing both oral and topical solutions.

2. Bayer AG

Bayer supplies the highly popular Canesten range to Qatar, a staple in retail pharmacies for treating various fungal skin and nail infections.

3. QLife Pharma

A key domestic manufacturer that contributes to Qatar's drug security by producing high-quality generic antifungal creams and ointments for local consumption.

4. Ebn Sina Medical

Qatar's premier distributor, managing the supply chain for multiple international dermatological brands and ensuring 24/7 availability across the country.

5. Novartis AG

Provides specialized antifungal medications through its Sandoz division, focusing on high-efficacy treatments for resistant fungal strains.

6. Julphar

A regional giant that exports a wide array of dermatological generics to Qatar, benefiting from GCC-wide therapeutic standards and logistics.

7. Glenmark Pharmaceuticals Ltd.

Noted for its strong dermatology portfolio, Glenmark supplies advanced topical antifungal formulations to Qatari private clinics and hospitals.

8. Hikma Pharmaceuticals PLC

A major supplier in the MENA region that provides specialized anti-infectives and skin treatments to Qatar's public and private sectors.

9. Viatris Inc.

Supplies a diverse portfolio of legacy antifungal brands and high-quality generics used in the chronic management of skin infections.

10. Tabuk Pharmaceuticals

A leading regional manufacturer that provides cost-effective antifungal tablets and creams, aligning with Qatar's healthcare affordability goals.

11. Sun Pharmaceutical Industries Ltd.

Exports high-standard generic dermatological products, maintaining a significant presence in the Qatari retail pharmacy segment.

12. Abbott Laboratories

Contributes to the market through advanced diagnostic tools and supportive skin health products that aid in the overall management of dermatological health.